Skip to main content
Caplight Logo









RightEye

RightEye

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://righteye.com/

Last Round

Debt

Mar 16, 2020

Total Funding Raised

$10.86M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

RightEye is a health technology company that has developed an eye-tracking technology designed to measure visual performance and track health issues.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Computer Vision, Healthcare Analytics, Medical AI, Sports & Fitness

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

eye-tracking technologybrain health assessmentmedical AIconcussion diagnosissports visionvision therapyneurological diagnosticsneuro-optometryeye movement analysisFDA-cleared medical deviceconcussion baseline testingreading assessmentbinocular vision testingoculomotor trainingsensorimotor exameye-tracking SDK

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RightEye Comparables

Compare RightEye with similar companies based on industry and business-model similarity.

RightEye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuroSync
84%
EyeGuide, Inc.
84%
WIVI Vision
82%

RightEye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMar 16, 2020
VC RoundNov 13, 2018
Series ASep 11, 2017
SeedMar 17, 2016
AngelMay 14, 2013

Key People

Founding team and executive leadership

Melissa Hunfalvay

Chief Product Officer Co-Founder, Board Of Directors

Founding Team

Frank Oelschlager

Interim CTO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 65% MoM, reaching 7.8K.

  • Jul 20, 2026

    Open roles increased to 11, 69% of headcount.

RightEye Filings

Explore SEC and related filing metadata, where available.

RightEye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RightEye's valuation, stock price, and market status.

Is RightEye a public or private company?

RightEye is a private company.

What is the current stock price of RightEye?

RightEye is a private company with no public stock price. No recent secondary market data is available.

How much is RightEye worth (valuation)?

Valuation information for RightEye is not publicly available.

Can I buy RightEye stock?

RightEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RightEye's last funding round?

RightEye's most recent funding round was Debt on March 16, 2020.

Who are the main investors in RightEye?

Investor information for RightEye is not publicly disclosed.

Will RightEye IPO soon?

No public IPO plans have been announced for RightEye.

How can I track RightEye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RightEye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range12
Year Founded2012
Last FundingMar 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?